- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 17.54M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $36M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $41.4M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.94M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.75M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.1M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.27M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.8M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $39.48M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $43.73M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $40.58M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $44.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.06M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $10K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.55M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $42.37M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $46.2M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.45M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.05M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.99M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.5M |